After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companie | ...

Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

Can-Fite BioPharma (CANF) announced that leading Medical Centers in the US are approaching the FDA, asking for compassionate use approval to ...

Parents of children with spinal muscular atrophy (SMA), a rare disease, welcomed the announcement by the Indian pharma ...

Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.

Natco Pharma started in Hyderabad with an investment of ₹3.3 million in 1981 and 20 employees working at a single unit. Today ...

Affordable generic version of SMA drug Risdiplam soon available in India, offering hope to patients and activists.

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

The stock prices of pharmaceutical firms increased on 11 April after US President Trump suspended his reciprocal tariffs for ...